Same evidence. Different decisions.

A treatment can gain scientific support before regulators, guideline committees, insurers, hospitals, or clinicians respond. And they don't always move in the same order. Explore where a change has reached, what remains unresolved, and what might move next.

· Phase 0 · registry-derived · not a performance measure

FF-001 · Sunvozertinib · first-line guideline listing

Evidence 133 days
→
Recognition 80 days
→
Authority 348 days
→

The evidence clock starts at the day the evidence existed and ends at the day it was detectable in public. The recognition clock ends when the estimate was frozen. The authority clock ends at the deadline. The event date is null for every unresolved record, so the chart stops at the deadline.

The same dates, two readings.

The left panel keeps the real dates on one axis. The right panel aligns each record to its own evidence date, so the shapes can be compared. The alignment is a reading aid, not a forecast.

As dated

Jan 16, 2026 → Jul 31, 2027

Aligned to the evidence

Each row starts at its own evidence date.

How far has the change gotten?

The registry holds records at three of the five steps. The other two are the frame the record moves through, not a count.

The dates behind the timelines

Evidence, recognition and authority intervals for six records
Record Evidence Recognition Authority Total
FF-064 0d14d115d 129d
FF-059 0d14d116d 130d
FF-062 0d14d116d 130d
FF-063 0d14d119d 133d
FF-003 133d116d190d 439d
FF-001 133d80d348d 561d

Days are calendar days between the registry's own dates. A zero means the two dates fall on the same day, not that the step was skipped.